CLINICAL SUPPLY MANAGEMENT ARTICLES
Sourcing Through The Tariff Mess: What 2026 Actually Means For Clinical Supply
US tariff changes are reshaping clinical supply sourcing. Learn how pharmaceutical duties, country-of-origin documentation and temporary import provisions affect trial materials.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.
-
Sponsors are recognizing the potential benefits of decentralized clinical trials, including reduced operational costs and improved recruitment and retention of more diverse patient populations.
-
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
Streamline clinical supply chain management with SmartSignals Supplies, reducing errors and inefficiencies from spreadsheet-based forecasting.
-
Personal legal responsibility, post-Brexit certification rules, and a three-part documentation review shape how investigational batches reach patients in the EU and UK, and how sponsors work with their certifying QP.
-
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.